MDRX

Allscripts Healthcare Solutions, Inc. (MDRX)

$15.75
*  
0.42
2.6%
Get MDRX Alerts
*Delayed - data as of Jul. 11, 2014  -  Find a broker to begin trading MDRX now
Exchange: NASDAQ
Industry: Technology
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time

Allscripts-Misys Healthcare Solutions, Inc. (MDRX)

February 27, 2013 3:00 pm ET

Executives

Richard J. Poulton - Chief Financial Officer

Seth Frank - Vice President of Investor Relations

Analysts

George Hill - Citigroup Inc, Research Division

Presentation

George Hill - Citigroup Inc, Research Division

[indiscernible] your attendance and listening on the webcast. This is my last presentation of the healthcare conference. I am very happy to have with us the management team from Allscripts. CFO, Rick Poulton; head of IR, Seth Frank. Guys, thank you very much for being here today.

Richard J. Poulton

Thank you, George.

George Hill - Citigroup Inc, Research Division

[indiscernible] right on. We're ready to go. Getting a little punchy at the end here. The theme of Citi's 2013 Healthcare Conference is the value imperative. Rick, I will just start off by asking you, can you give the audience a little overview of what Allscripts does and detail how the company fulfills the need to create value for providers in the U.S. healthcare system?

Richard J. Poulton

Sure. So yes, we are a software technology company. Our stated vision is to deliver a connected community of health, and we do that through a very Open Architecture strategy. So our core baseline products are Electronic Health Records. We have a comprehensive suite of offerings, both for the inpatient side of healthcare, as well as the outpatient side as well and post acute. So we're -- we have arguably one of the largest footprints today plus the most clinicians out there, and we look to defend and grow that base.

George Hill - Citigroup Inc, Research Division

Okay. That's a great overview. It's been a time of rapid change at Allscripts if you look back over the last year. Paul couldn't be with us today. I'm sure he's -- hopefully, he's out standing in front of clients or prospects. And you, obviously, have to work closely with Paul. He's been head of the organization a little bit more -- a little more than 60 days. Can you talk about the impact Paul has had, I'd say, inside of merchandise mar [ph] and out?

Richard J. Poulton

Sure. So I'll start by confirming what you asked. Paul would love to be here today, but we've had him literally living out of a suitcase for the last 60 days. He was out on Long Island this morning, -- meeting with and addressing the leadership team of our largest client, which is North Shore-Long Island Jewish Health Systems. So he's been out there all day. He is working the New York area a little bit, but unfortunately, he couldn't get to drop by here.

Paul has had a wonderful impact so far. I mean for those of you who don't know, Paul is an industry veteran, cut his teeth at one of our competitors, Cerner, for an awfully long time, left there as their Chief Operating Officer, but very much a sales background and is quite familiar particularly with the clients in the acute space. He's, by last count, has addressed more than 60 of our customers direct, so he's averaging better than one a day since he's arrived. And he's done that. And that kind of tireless energy combined with his messaging to the clients that we're here for the long haul and we are here to address the needs that we -- all the commitments we've previously made, we're going to address, and we're also going to be here to deliver long-term solutions to them. So he made's -- he's had a very good impact, I think, on the client base but also on the employee base as well. Employees also see this as -- it's been a tumultuous year for the employee group, and this is now representative of a real calming influence.

Richard J. Poulton

That's great. Can you talk a little bit about what has been the perception -- has any of the messaging changed to customers? I've known Paul personally a long time. I know Paul is a high-service guy, and that's going to be what he promises the customers. I know that Allscript's message has always been a level of high service. What have been the subtle changes of Paul's message to customers versus what has been the prior messaging to customers?

Richard J. Poulton

Well, it started with, again, I mean the -- last year for Allscripts has been a little bit rocky, a lot of internal strife at the board level initially, and then we had gone through a strategic alternatives process through the fall last year. It created a lot of question marks, I think, maybe doubts in some cases in some our clients' minds about whether we were in this for the long term or not. And so I think Paul's main theme as he gets out is to reassure people that we are. And we're not just saying that we're backing it up to we'll make by far the largest investment in our product portfolio that's ever been made in the company's history this year, and I think that's the main message that really Paul is trying to get across to everybody there. We are here to support them for the long term.

George Hill - Citigroup Inc, Research Division

Yes. And I'll ask then, the first part of that is, what has been the initial feedback from clients? And people that we've spoken to, it's been very encouraging and the market wants you to be successful. The market wants more options, not less options. So I guess, what is the initial feedback maybe -- I said, maybe for your clients, and then some prospects that you've been in [indiscernible]?

Read the rest of this transcript for free on seekingalpha.com